News & Trends - Pharmaceuticals
Vaccination accounts for almost half of mortality decline in infants
Pharma News: Researchers have mapped the impact of vaccines to mark the 50-year anniversary of the Expanded Programme on Immunisation (EPI).
The findings show that since 1974, vaccination has saved approximately 154 million lives – most of these children under the age of five.
“We estimate that the EPI has provided the single greatest contribution to infant survival over the past 50 years,” said Associate Professor Andrew Shattock, Intervention and Infectious Diseases Modelling Team at Telethon Kids Institute and University of Western Australia.
Hue further added “The collaborative efforts of countries around the world to implement the EPI has averted approximately 154 million deaths – significantly, around 146 million children under the age of five. The study found that for every death averted, 66 years of full health were gained, on average.”
The EPI was an initiative established by the World Health Assembly in 1974 with the goal to vaccinate all children against smallpox, tuberculosis, diphtheria, tetanus, pertussis, polio and measles by 1990. The program was then expanded to include other diseases.
The findings estimated that vaccination had accounted for 40% of the observed decline in global infant mortality.
“In 2024 a child at any age under 10 years is 40% more likely to survive to their next birthday thanks to vaccination efforts over the past 50 years. Increased survival probability is observed even well into late adulthood. We also discovered that measles vaccination accounted for 60% of the total benefit of vaccination over the 50-year period, which was also the greatest driver of lives saved,” Associate Professor Shattock explained.
“We are at an historic moment in infectious disease control. The next 50 years will require improvements in targeting and reach amid future complex realities for unvaccinated and under-vaccinated children and communities. Continuous engagement of communities in vaccine uptake is crucial since hard won gains can so easily be lost,” the authors concluded.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Lilly’s drug cuts diabetes risk by 94%, so why is it still not on the PBS?
On World Diabetes Day (14 November), new data reveals that three years of treatment with a GIP/GLP-1 receptor agonist significantly […]
MoreNews & Trends - Biotechnology
Depaz Oration to celebrate an ‘enduring’ legacy in the biotech sector
AusBiotech announced the establishment of the Depaz Oration, an annual keynote event that will debut at the AusBiotech Conference in […]
MoreNews & Trends - Pharmaceuticals
Government calls for public input on genomic-led cancer care
The Australian Government has launched a public consultation on a draft policy framework aimed at enhancing genomics-informed cancer care nationwide. […]
MoreNews & Trends - MedTech & Diagnostics
Can the patient voice reduce low-value care? Australia’s first large-scale hospital initiative seeks answers
In an Australian-first, a not-for-profit private health insurer will ask hospital patients to rate not only their clinical care but […]
More